期刊文献+

可溶性CD44v6及基质金属蛋白酶-2与子宫内膜异位症 被引量:1

EXPRESSION AND SIGNIFICANCE OF SOLUBLE CD44v6 AND MMP-2 IN HUMAN ENDOMETRIOSIS
下载PDF
导出
摘要 目的检测可溶性粘附分子CD44v6及基质金属蛋白酶-2(MMP-2)在正常妇女与子宫内膜异位症患者血清及腹腔液中的水平,探讨其在EMT发病中的作用。方法用酶联免疫吸附法(ELISA)检测正常妇女与EMT患者血清、腹腔液中可溶性CD44v6与MMP-2的水平。结果可溶性CD44v6、MMP-2在EMT患者血清、腹腔液中的水平显著高于正常妇女(P<0.05),EMT组血清中及腹腔液中可溶性CD44v6与MMP-2的表达有高度相关性(r=0.732,0.853;P<0.05)。结论 EMT患者腹腔液、血清中可溶性CD44v6与MMP-2的高表达密切相关;CD44v6、MMP-2的异常高表达促进了异位内膜细胞的粘附与侵袭,促进了EMT的发生发展。 Objective To evaluate the changes of serum and ascites levels of soluble CD44v6 and MMP-2 in women with endometriosis and nomal women. Methods Enzyme-linked immunosorbent ashy (ELISA)was used to measure serum and ascites soluble CD44v6 and MMP-2 from 40 women with endometriosis and 35 nomal women. Results The soluble CD44v6 and MMP-2 levels in serum and ascites in EMT patients were significantly higher than those in normal women( P 〈 0.01 ). Conclusion There exists close relationship between CD44v6 and MMP-2, and the soluble CD44v6 and MMP-2 levels are significantly higher in serum and ascites in EMT patients than those in nomal women. CD44v6 and MMP-2 could be involved in the development of EMT.
作者 张珍
机构地区 临沂市人民医院
出处 《山东医学高等专科学校学报》 2011年第1期9-11,共3页 Journal of Shandong Medical College
关键词 CD44V6 基质金属蛋白酶-2 子宫内膜异位症 酶联免疫吸附试验 CD44v6 Matrix metal loproteinase-2 Endometriosis Enzyme-linked Immunosorbent assay
  • 相关文献

参考文献8

  • 1连利娟,等.妇科肿瘤学[M].北京:人民卫生出版社,1996:359.
  • 2Brincat M,Galea R,Buhagiar A.Poiycystic ovarias and endometriosis:a possible connection[J].Br I Obster Gynecol,1994,104(4):346.
  • 3Cornillre FI,Osterllynck D,Lauweryns JM,et al.Deeply infi ltrating Pelevic endometriosis is histology and clinical significanq[J].Festril Steril,1990,53(6):978.
  • 4Gaetje R,Kotzian S,Herrmann G,et al.Nonmalignant epithelial cell,Potentially invasive in human endomtrosis,Lack the tumor Suppressor molecule E-cadherin[J].Am J pathol,1997,150(2):461-467.
  • 5Gagné D,Rivard M,Pagé M,et al.Blood leukocyte subsets are modulated in patients with endometriosis[J].Fertil Steril,2003,80(1):43-53.
  • 6Seiter S,Arch R,Reber S.et al.Prevention of tumor metastasis formation by antivariant CD44v6[J].Exp Med,1994,177(2):443-455.
  • 7Wojtowicz-Praga S.Clinical potential of matrix metalloprotease inhibitors[J].Drugs R D,1999,1(2):117-129.
  • 8郭立霞,谢弘.CD44与肿瘤转移[J].生命科学,2001,13(2):60-63. 被引量:11

二级参考文献7

  • 1Choi S H,Int J Cancer,2000年,85卷,523页
  • 2Yamaguchi A,Oncol Rep,2000年,7卷,541页
  • 3Lou W,Cancer Res,1999年,59卷,2329页
  • 4Chiu R K,Exp Cell Res,1999年,248卷,314页
  • 5Gao A C,Cancer Res,1997年,57卷,846页
  • 6Sy M,Curr Opin Onco,1997年,9卷,108页
  • 7Sy M,J Exp Mol,1991年,174卷,859页

共引文献15

同被引文献16

  • 1隆亚明.米非司酮联合手术治疗子宫内膜异位症疗效观察[J].中国误诊学杂志,2007,7(19):4520-4521. 被引量:16
  • 2Ulrich U,Richter O,Wardelmann E. Endometrioseundmalignore[J].Zentrlbl Gynakol,2009,(02):239-242.
  • 3Yoshikawa H,Jimbo H,Okada S. Prevalence of endometriosis in ovarian cancer[J].{H}Gynecologic and Obstetric Investigation,2008,(Suppl 1):11-17.
  • 4Fascialli A,D'Ambrogio G,Booci G. Vascular endothelial growth factor and interleukin 8 in ovarian cystic pathology[J].{H}Fertility and Sterility,2010,(06):1218-1221.
  • 5Collette T,Bellehumeur C,Kats R. Evidence for an increased release of proteolytie activity by the eutopie endometrial tissue in women with endometriosis and for involvement of marx metalloproteinase-9[J].{H}Human Reproduction,2008,(06):1257-1264.
  • 6Collette T,Maheux R,Mailloux J. Increased expression of matrix metal loproteinase-9 in the eutopic endometrial tissue of women with endometriosis[J].{H}Human Reproduction,2010,(12):3059-3067.
  • 7Tran KL,Osteen KG,Taylor HS. ratrol inhibits evelopment of experimental endomeniosis in vivo and reduces endomenial tromal cell invasiveness in vitro[J].{H}Biology of Reproduction,2011,(01):106-112.
  • 8Mori T,Yamasaki S,Masui F. Suppression of the development of experimentally induced uterine adenomyosis by a novel matrix metalloproteinase inhibitor,ONO-4817,in mice[J].{H}Exp Biol Med(Maywood),2009,(05):429.
  • 9罗晓.腹腔镜联合药物治疗子宫内膜异位症的疗效观察[J].实用妇产科杂志,2008,24(10):616-618. 被引量:25
  • 10陈瑾,黄守国,吴清萍,陈芳.米非司酮治疗子宫内膜异位症的疗效及其机制探讨[J].山东医药,2011,51(14):81-82. 被引量:22

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部